# reload+after+2024-01-21 22:44:35.681556
address1§1035 Cambridge Street
address2§Suite 18A
city§Cambridge
state§MA
zip§02141
country§United States
phone§212 582 1199
website§https://eternatx.com
industry§Biotechnology
sector§Healthcare
longBusinessSummary§Eterna Therapeutics Inc. operates as a preclinical-stage, biopharmaceutical company. The company offers Synthetic mRNA, ToRNAdo mRNA Delivery, mRNA Gene Editing, and mRNA Cell Reprogramming. It also develops therapies and medicines using gene-editing proteins and cell therapy technology for the treatment of oncology, blood disorder, and monogenic disease. The company was formerly known as Brooklyn ImmunoTherapeutics, Inc. and changed its name to Eterna Therapeutics Inc. in October 2022. Eterna Therapeutics Inc. is based in Cambridge, Massachusetts.
fullTimeEmployees§9
companyOfficers§[{'maxAge': 1, 'name': 'Mr. Sanjeev  Luther', 'title': 'CEO, President & Director', 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Sandra M. Gurrola', 'age': 56, 'title': 'Principal Financial & Accounting Officer and VP of Finance', 'yearBorn': 1967, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Megan  Yung', 'title': 'Chief Strategy Officer', 'exercisedValue': 0, 'unexercisedValue': 0}]
maxAge§86400
priceHint§4
payoutRatio§0.0
beta§8.501
priceToSalesTrailing12Months§203.62996
currency§USD
dateShortInterest§1702598400
forwardEps§-9.6
exchange§NCM
quoteType§EQUITY
shortName§Eterna Therapeutics Inc.
longName§Eterna Therapeutics Inc.
firstTradeDateEpochUtc§683472600
timeZoneFullName§America/New_York
timeZoneShortName§EST
uuid§280db8c6-d665-3e8c-aebc-b7fe5ee139e0
gmtOffSetMilliseconds§-18000000
recommendationMean§3.0
recommendationKey§hold
quickRatio§0.657
grossMargins§-2.33333
ebitdaMargins§0.0
trailingPegRatio§None
